Global (United States, European Union and China) Influenza Drugs Market Research Report 2019-2025

Table of Contents

1 Influenza Drugs Market Overview

• 1.1 Product Overview and Scope of Influenza Drugs
• 1.2 Influenza Drugs Segment by Type
  • 1.2.1 Global Influenza Drugs Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Zanamivir
  • 1.2.3 Oseltamivir Phosphate
  • 1.2.4 Peramivir
  • 1.2.5 Other Influenza Drugs
• 1.3 Influenza Drugs Segment by Application
  • 1.3.1 Influenza Drugs Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Adults
  • 1.3.3 Chidren
• 1.4 Global Influenza Drugs Market Size Estimates and Forecasts
  • 1.4.1 Global Influenza Drugs Revenue 2015-2026
  • 1.4.2 Global Influenza Drugs Sales 2015-2026
  • 1.4.3 Influenza Drugs Market Size by Region: 2020 Versus 2026

2 Global Influenza Drugs Market Competition by Manufacturers

• 2.1 Global Influenza Drugs Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Influenza Drugs Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Influenza Drugs Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Influenza Drugs Manufacturing Sites, Area Served, Product Type
• 2.5 Influenza Drugs Market Competitive Situation and Trends
  • 2.5.1 Influenza Drugs Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Influenza Drugs Players (Opinion Leaders)

3 Influenza Drugs Retrospective Market Scenario by Region

• 3.1 Global Influenza Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Influenza Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Influenza Drugs Market Facts & Figures by Country
  • 3.3.1 North America Influenza Drugs Sales by Country
  • 3.3.2 North America Influenza Drugs Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Influenza Drugs Market Facts & Figures by Country
  • 3.4.1 Europe Influenza Drugs Sales by Country
  • 3.4.2 Europe Influenza Drugs Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Influenza Drugs Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Influenza Drugs Sales by Region
  • 3.5.2 Asia Pacific Influenza Drugs Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Influenza Drugs Market Facts & Figures by Country
  • 3.6.1 Latin America Influenza Drugs Sales by Country
  • 3.6.2 Latin America Influenza Drugs Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Influenza Drugs Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Influenza Drugs Sales by Country
  • 3.7.2 Middle East and Africa Influenza Drugs Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Influenza Drugs Historic Market Analysis by Type

• 4.1 Global Influenza Drugs Sales Market Share by Type (2015-2020)
• 4.2 Global Influenza Drugs Revenue Market Share by Type (2015-2020)
• 4.3 Global Influenza Drugs Price Market Share by Type (2015-2020)
• 4.4 Global Influenza Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Influenza Drugs Historic Market Analysis by Application

• 5.1 Global Influenza Drugs Sales Market Share by Application (2015-2020)
• 5.2 Global Influenza Drugs Revenue Market Share by Application (2015-2020)
• 5.3 Global Influenza Drugs Price by Application (2015-2020)

6 Company Profiles and Key Figures in Influenza Drugs Business

• 6.1 Bristol-Myers Squibb]
  • 6.1.1 Corporation Information
  • 6.1.2 Bristol-Myers Squibb] Description, Business Overview and Total Revenue
  • 6.1.3 Bristol-Myers Squibb] Influenza Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Bristol-Myers Squibb] Products Offered
  • 6.1.5 Bristol-Myers Squibb] Recent Development
• 6.2 AstraZeneca
  • 6.2.1 AstraZeneca Influenza Drugs Production Sites and Area Served
  • 6.2.2 AstraZeneca Description, Business Overview and Total Revenue
  • 6.2.3 AstraZeneca Influenza Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 AstraZeneca Products Offered
  • 6.2.5 AstraZeneca Recent Development
• 6.3 Eli Lilly
  • 6.3.1 Eli Lilly Influenza Drugs Production Sites and Area Served
  • 6.3.2 Eli Lilly Description, Business Overview and Total Revenue
  • 6.3.3 Eli Lilly Influenza Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 Eli Lilly Products Offered
  • 6.3.5 Eli Lilly Recent Development
• 6.4 Roche
  • 6.4.1 Roche Influenza Drugs Production Sites and Area Served
  • 6.4.2 Roche Description, Business Overview and Total Revenue
  • 6.4.3 Roche Influenza Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Roche Products Offered
  • 6.4.5 Roche Recent Development
• 6.5 GlaxoSmithKline
  • 6.5.1 GlaxoSmithKline Influenza Drugs Production Sites and Area Served
  • 6.5.2 GlaxoSmithKline Description, Business Overview and Total Revenue
  • 6.5.3 GlaxoSmithKline Influenza Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 GlaxoSmithKline Products Offered
  • 6.5.5 GlaxoSmithKline Recent Development
• 6.6 Novartis
  • 6.6.1 Novartis Influenza Drugs Production Sites and Area Served
  • 6.6.2 Novartis Description, Business Overview and Total Revenue
  • 6.6.3 Novartis Influenza Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Novartis Products Offered
  • 6.6.5 Novartis Recent Development
• 6.7 Pfizer
  • 6.6.1 Pfizer Influenza Drugs Production Sites and Area Served
  • 6.6.2 Pfizer Description, Business Overview and Total Revenue
  • 6.6.3 Pfizer Influenza Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Pfizer Products Offered
  • 6.7.5 Pfizer Recent Development
• 6.8 Sanofi Pasteur
  • 6.8.1 Sanofi Pasteur Influenza Drugs Production Sites and Area Served
  • 6.8.2 Sanofi Pasteur Description, Business Overview and Total Revenue
  • 6.8.3 Sanofi Pasteur Influenza Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 Sanofi Pasteur Products Offered
  • 6.8.5 Sanofi Pasteur Recent Development
• 6.9 Bayer
  • 6.9.1 Bayer Influenza Drugs Production Sites and Area Served
  • 6.9.2 Bayer Description, Business Overview and Total Revenue
  • 6.9.3 Bayer Influenza Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.9.4 Bayer Products Offered
  • 6.9.5 Bayer Recent Development
• 6.10 Celgene
  • 6.10.1 Celgene Influenza Drugs Production Sites and Area Served
  • 6.10.2 Celgene Description, Business Overview and Total Revenue
  • 6.10.3 Celgene Influenza Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.10.4 Celgene Products Offered
  • 6.10.5 Celgene Recent Development
• 6.11 Seqirus
  • 6.11.1 Seqirus Influenza Drugs Production Sites and Area Served
  • 6.11.2 Seqirus Influenza Drugs Description, Business Overview and Total Revenue
  • 6.11.3 Seqirus Influenza Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.11.4 Seqirus Products Offered
  • 6.11.5 Seqirus Recent Development
• 6.12 Protein Sciences Corporation
  • 6.12.1 Protein Sciences Corporation Influenza Drugs Production Sites and Area Served
  • 6.12.2 Protein Sciences Corporation Influenza Drugs Description, Business Overview and Total Revenue
  • 6.12.3 Protein Sciences Corporation Influenza Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.12.4 Protein Sciences Corporation Products Offered
  • 6.12.5 Protein Sciences Corporation Recent Development
• 6.13 Serum Institute of India
  • 6.13.1 Serum Institute of India Influenza Drugs Production Sites and Area Served
  • 6.13.2 Serum Institute of India Influenza Drugs Description, Business Overview and Total Revenue
  • 6.13.3 Serum Institute of India Influenza Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.13.4 Serum Institute of India Products Offered
  • 6.13.5 Serum Institute of India Recent Development
• 6.14 Emergent Biosolutions
  • 6.14.1 Emergent Biosolutions Influenza Drugs Production Sites and Area Served
  • 6.14.2 Emergent Biosolutions Influenza Drugs Description, Business Overview and Total Revenue
  • 6.14.3 Emergent Biosolutions Influenza Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.14.4 Emergent Biosolutions Products Offered
  • 6.14.5 Emergent Biosolutions Recent Development
• 6.15 BioCryst Pharmaceuticals
  • 6.15.1 BioCryst Pharmaceuticals Influenza Drugs Production Sites and Area Served
  • 6.15.2 BioCryst Pharmaceuticals Influenza Drugs Description, Business Overview and Total Revenue
  • 6.15.3 BioCryst Pharmaceuticals Influenza Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.15.4 BioCryst Pharmaceuticals Products Offered
  • 6.15.5 BioCryst Pharmaceuticals Recent Development
• 6.16 Alvogen
  • 6.16.1 Alvogen Influenza Drugs Production Sites and Area Served
  • 6.16.2 Alvogen Influenza Drugs Description, Business Overview and Total Revenue
  • 6.16.3 Alvogen Influenza Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.16.4 Alvogen Products Offered
  • 6.16.5 Alvogen Recent Development

7 Influenza Drugs Manufacturing Cost Analysis

• 7.1 Influenza Drugs Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Influenza Drugs
• 7.4 Influenza Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Influenza Drugs Distributors List
• 8.3 Influenza Drugs Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Influenza Drugs Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Influenza Drugs by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Influenza Drugs by Type (2021-2026)
• 10.2 Influenza Drugs Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Influenza Drugs by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Influenza Drugs by Application (2021-2026)
• 10.3 Influenza Drugs Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Influenza Drugs by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Influenza Drugs by Region (2021-2026)
• 10.4 North America Influenza Drugs Estimates and Projections (2021-2026)
• 10.5 Europe Influenza Drugs Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Influenza Drugs Estimates and Projections (2021-2026)
• 10.7 Latin America Influenza Drugs Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Influenza Drugs Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List